1. Home
  2. PRPO vs CMND Comparison

PRPO vs CMND Comparison

Compare PRPO & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • CMND
  • Stock Information
  • Founded
  • PRPO N/A
  • CMND 2017
  • Country
  • PRPO United States
  • CMND Canada
  • Employees
  • PRPO N/A
  • CMND N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • CMND Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRPO Industrials
  • CMND Health Care
  • Exchange
  • PRPO Nasdaq
  • CMND Nasdaq
  • Market Cap
  • PRPO 9.9M
  • CMND 6.5M
  • IPO Year
  • PRPO N/A
  • CMND N/A
  • Fundamental
  • Price
  • PRPO $7.22
  • CMND $1.41
  • Analyst Decision
  • PRPO
  • CMND
  • Analyst Count
  • PRPO 0
  • CMND 0
  • Target Price
  • PRPO N/A
  • CMND N/A
  • AVG Volume (30 Days)
  • PRPO 5.9K
  • CMND 97.5K
  • Earning Date
  • PRPO 03-28-2025
  • CMND 01-22-2025
  • Dividend Yield
  • PRPO N/A
  • CMND N/A
  • EPS Growth
  • PRPO N/A
  • CMND N/A
  • EPS
  • PRPO N/A
  • CMND N/A
  • Revenue
  • PRPO $17,411,000.00
  • CMND N/A
  • Revenue This Year
  • PRPO $75.18
  • CMND N/A
  • Revenue Next Year
  • PRPO N/A
  • CMND N/A
  • P/E Ratio
  • PRPO N/A
  • CMND N/A
  • Revenue Growth
  • PRPO 31.31
  • CMND N/A
  • 52 Week Low
  • PRPO $4.31
  • CMND $0.95
  • 52 Week High
  • PRPO $7.55
  • CMND $2.30
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 62.56
  • CMND 49.60
  • Support Level
  • PRPO $7.02
  • CMND $1.35
  • Resistance Level
  • PRPO $7.55
  • CMND $1.43
  • Average True Range (ATR)
  • PRPO 0.25
  • CMND 0.09
  • MACD
  • PRPO 0.05
  • CMND -0.00
  • Stochastic Oscillator
  • PRPO 73.78
  • CMND 43.75

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: